AngioDynamics, Inc. (ANGO) vs CorMedix Inc. (CRMD)

A side-by-side comparison of AngioDynamics, Inc. and CorMedix Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANGO vs CRMD

growth of $100 · dividends reinvested · last 10y
ANGO -10.1% (-1.1%/yr)CRMD -48.3% (-6.4%/yr)ANGO compounded faster over this window
050100150Start $10020182020202220242026$90$52
ANGO CRMD

ANGO vs CRMD: by the numbers

  • •ANGO is the larger company ($596M vs $571M market cap).
  • •CRMD is profitable (40.49% net margin) while ANGO runs a net loss (-11.48%).
  • •CRMD grew revenue faster over the past five years (352.03% vs 1.93% CAGR).

Metrics side by side

Valuation

MetricANGOCRMD
P/E ratioN/A3.42
Forward P/EN/A14.71
P/S ratio1.861.24
P/B ratio3.491.24
EV / EBITDAN/A1.82
FCF yield0.09%43.82%

Profitability

MetricANGOCRMD
Gross margin54.62%82.78%
Operating margin-12.47%46.95%
Net margin-11.48%40.49%
ROE-21.51%40.62%
ROIC-20.75%27.87%

Growth (annualized)

MetricANGOCRMD
Revenue CAGR (5Y)1.93%352.03%
FCF CAGR (5Y)-51.49%N/A
Total return CAGR (5Y)-10.80%9.70%

Frequently asked

Which has grown faster, ANGO or CRMD?
Over the past five years, CRMD grew revenue faster — ANGO at a 1.93% CAGR versus CRMD at 352.03%.
Is ANGO or CRMD more profitable?
CRMD runs the higher net margin — ANGO at -11.48% versus CRMD at 40.49%.
How have ANGO and CRMD total returns compared?
Over the past 10 years, ANGO delivered -0.58% and CRMD delivered -7.74% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.